One Medical has surged 168% since going public. One Wall Street analyst lays out 4 reasons investors should be skeptical of the hot primary-care company. (ONEM)

One Medical has surged 168% since going public. One Wall Street analyst lays out 4 reasons investors should be skeptical of the hot primary-care company. (ONEM)

Business Insider

Published

· Primary-care upstart One Medical went public at the end of January, selling shares for $14 each. The stock has surged since the IPO.
· SVB Leerink analyst Stephen Tanal initiated coverage of One Medical on July 1, giving the stock a $36 price target and rating it market perform. 
· There are four main risks weighing on...

Full Article